Josh has worked with NEA since 1995 and recently became a General Partner on their healthcare team leading the medtech/healthtech practice. Josh is the Founder & Executive Chairman of ExploraMed, a medical device incubator creating 8 companies. Transactions from the ExploraMed portfolio include NeoTractm acquired by Teleflex, Acclarent, acquired by J&J, EndoMatrix, acquired by C.R. Bard & TransVascular, acquired by Medtronic. Other ExploraMed/NEA ventures include Moximed, Nuelle and Willow. Josh serves on the faculty of the Stanford University Medical School as a Adjunct Professor of Medicine and is Co-Founder of Stanford’s Biodesign Innovation Program. Josh serves on the board of Setpoint Medical, DOTS Devices, Eargo, ExploraMed, Intrinsic Therapeutics, Moximed, Willow and Coravin. Josh holds over 300 patents and patent applications. He received an MBA from Columbia University, an MD from the NYU School of Medicine, and a bachelor’s degree in Mechanical Engineering from MIT.